ライフサイエンスコーパス: fine-needle aspiration biopsy

1 ture of thyroid abscess material obtained by fine-needle aspiration biopsy.

2 ion for thyroid nodules is ultrasound-guided fine-needle aspiration biopsy.

3 ere found to be papillary thyroid cancers at fine-needle aspiration biopsy.

4 st studies, nodule cytology was evaluated by fine-needle aspiration biopsy.

5 graphic follow-up had been recommended after fine-needle aspiration biopsy.

6 important issue undermining the benefits of fine-needle aspiration biopsy.

7 Fine-needle aspiration biopsy also allows characterizati

8 te thyroid nodules; and peripheral blood and fine-needle aspiration biopsy analysis of molecular mark

9 e diagnosis was made using ultrasound-guided fine needle aspiration biopsy and consequent cytopatholo

10 pplied to improve the diagnostic accuracy of fine needle aspiration biopsy and cytologic examination.

11 Fine-needle aspiration biopsy and core biopsy are import

12 ee detection of Tg in the needle washouts of fine-needle aspiration biopsies, at concentrations usefu

13 Percutaneous fine-needle aspiration biopsy can be used for the diagno

14 Fine-needle aspiration biopsy confirmed the diagnoses (n

15 Clear corneal fine-needle aspiration biopsy confirmed the diagnosis as

16 versely, some population-based studies using fine-needle aspiration biopsy data report no linkage bet

17 lly or histologically proved after US-guided fine-needle aspiration biopsy (eight lesions) or core bi

18 Endosonography-guided fine-needle aspiration biopsy (EUS-FNA) permits cytologi

19 The preferred approach when repeated fine-needle aspiration biopsy fails to yield an adequate

20 chnology now allow the detection of these in fine needle aspiration biopsies (FNA).

21 The majority of nodules with fine needle aspiration biopsy (FNAB) results that are cl

22 Perform the first in vivo examination of fine needle aspiration biopsy (FNAB) scleral tracts to d

23 orphological evaluation can be acquired with fine-needle aspiration biopsies (FNAB) controlled with C

24 s with posterior uveal melanoma evaluated by fine-needle aspiration biopsy (FNAB) at the time of or s

25 Fine-needle aspiration biopsy (FNAB) for DNA amplificati

26 Fine-needle aspiration biopsy (FNAB) of tumor for DNA am

27 most potentially devastating complication of fine-needle aspiration biopsy (FNAB) or open biopsy is e

28 utility of BRAF mutation testing of thyroid fine-needle aspiration biopsy (FNAB) specimens for preop

29 9 to July 2013 who underwent prognostication fine-needle aspiration biopsy (FNAB) were included.

30 8q, as well as sex, source of tumor tissue (fine-needle aspiration biopsy [FNAB] compared with tumor

31 m tumors were conducted and compared with 86 fine-needle aspiration biopsies(FNAB) of lung and medias

32 5 brachytherapy and underwent intraoperative fine-needle aspiration biopsy for cytopathology and uvea

33 Fine-needle aspiration biopsy for metastatic prognostica

34 Fine-needle aspiration biopsy for prognostication in cho

35 Mutation analysis in thyroid nodule fine needle aspiration biopsy has been applied to improv

36 Core-needle biopsy in comparison to fine-needle aspiration biopsy has more frequent rate of

37 Fine-needle aspiration biopsy has resulted in substantia

38 Fine-needle aspiration biopsy identifies the childhood t

39 iomarkers that could improve the accuracy of fine needle aspiration biopsy in the evaluation of patie

40 in one patient and a percutaneous CT-guided fine needle aspiration biopsy in the other disclosed nor

41 US-guided fine-needle aspiration biopsy is a simple, rapid, inexpe

42 Fine-needle aspiration biopsy is an alternative to open

43 Fine-needle aspiration biopsy is both accurate and cost-

44 Fine-needle aspiration biopsy is more reliable in distin

45 Fine-needle aspiration biopsy is not perfect and adjunct

46 Tissue sampling with fine-needle aspiration biopsy is recommended.

47 Fine-needle aspiration biopsy is the standard diagnostic

48 sibly followed by computed tomography-guided fine-needle aspiration biopsy, is best.

49 Fine-needle aspiration biopsy MT for BRAF, RAS, PAX8-PPA

50 ression data (gene chips) was generated from fine-needle aspiration biopsies (n = 229) prospectively

51 l line were originated simultaneously from a fine needle aspiration biopsy of a metastasis in a patie

52 etrieve lower respiratory tract samples; and fine needle aspiration biopsy of lymph nodes.

53 Fine needle aspiration biopsy of tumors was done at base

54 trations of human Tg from needle washouts of fine-needle aspiration biopsies of thyroid nodule from d

55 0 for "highly suggestive of malignancy." For fine-needle aspiration biopsy of a palpable lump perform

56 The diagnosis was made by fine-needle aspiration biopsy of a pulmonary nodule.

57 Fine-needle aspiration biopsy of choroidal melanoma offe

58 ry 2012 to December 2014 from intraoperative fine-needle aspiration biopsy of choroidal tumors underg

59 Fine-needle aspiration biopsy of large thyroid nodules h

60 d ultrasonography and ultrasonography-guided fine-needle aspiration biopsy of nodules at least 1 cm i

61 nodes and as a guidance system for directed fine-needle aspiration biopsy of suspicious lesions.

62 Ultrasound (US)-guided fine-needle aspiration biopsy of the largest node reveal

63 Ultrasonography (US)-guided fine-needle aspiration biopsy of the left anterior chest

64 l melanoma may be directed by the results of fine-needle aspiration biopsy of the primary tumor.

65 r vitrectomy followed by transvitrector port fine-needle aspiration biopsy of the tumor immediately b

66 abilities, either computed tomography-guided fine-needle aspiration biopsy or positron emission tomog

67 16 of 680) of malignancies would not undergo fine-needle aspiration biopsy or surgery if the SRU guid

68 Either fine-needle aspiration biopsy or ultrasonography is reco

69 Studies were included if 1) mammography, fine-needle aspiration biopsy, or core-needle biopsy was

70 oid cancer incidence is increasing, and when fine-needle aspiration biopsy results are cytologically

71 w curved linear-array instruments, real-time fine-needle aspiration biopsy (RTFNA) of pancreatic lesi

72 d cancer that are beginning to be applied in fine needle aspiration biopsy samples to improve diagnos

73 tive review of 2,988 consecutive stereotaxic fine-needle aspiration biopsy samples of nonpalpable bre

74 MN/CA9 protein in histological sections and fine-needle aspiration biopsy smears of normal kidney, b

75 differential diagnosis of thyroid tumors by fine needle aspiration biopsy, specifically suspicious o

76 an algorithm for prospective MT of in-house fine-needle aspiration biopsy specimens, we conducted a

77 onography (US)-guided core biopsy, US-guided fine-needle aspiration biopsy, surgical excision, and mu

78 ly can augment the diagnostic specificity of fine-needle aspiration biopsy to better differentiate cy

79 Fine needle aspiration biopsy was done and revealed no a

80 Fine-needle aspiration biopsy was used in 10 cases and c

81 A total of 209 fine-needle aspiration biopsies were performed on 156 pa

82 at, gray-scale thyroid ultrasonography and a fine-needle aspiration biopsy were performed.

83 ary nodal metastases confirmed by results of fine-needle aspiration biopsy who had a clip placed in t